BIONOMICS LIMITED - Announcements

Currently unlisted. Add to my watchlist

Bionomics Limited (Bionomics) is an Australia-bases clinical-stage biopharmaceutical... Bionomics Limited (Bionomics) is an Australia-bases clinical-stage biopharmaceutical company. The Company is focused on developing a pipeline of novel, ion channel targeting drug candidates designed to transform the lives of patients suffering from serious central nervous system (CNS) disorders. The Company operates in drug development segment in Australia. The Company is advancing its lead drug candidate, BNC210, which is an oral, proprietary, selective negative allosteric modulator of the a7 nicotinic acetylcholine receptor, for the acute treatment of Social Anxiety Disorder (SAD) and chronic treatment of Post-Traumatic Stress Disorder (PTSD). The Company has two drugs in early-stage clinical trials for the treatment of cognitive deficits in Alzheimer’s disease and other central nervous system conditions.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

BNO	Ceasing to be a substantial holder		21/12/15	121.97KB	Share
BNO	Letter to Shareholders		17/12/15	4.35MB	Share
BNO	Change of Director's Interest Notice		16/12/15	72.87KB	Share
BNO	Ceasing to be a substantial holder		14/12/15	88.24KB	Share
BNO	Cleansing Notice		10/12/15	126.31KB	Share
BNO	Appendix 3B		10/12/15	120.8KB	Share
BNO	BNC210 Post Traumatic Stress Disorder Trial & Capital Raise	PRICE SENSITIVE	08/12/15	131.17KB	Share
BNO	Trading Halt	PRICE SENSITIVE	04/12/15	98.28KB	Share
BNO	Appendix 3B		30/11/15	119.37KB	Share
BNO	Final Director's Interest Notice		19/11/15	63.84KB	Share
BNO	Annual General Meeting 2015 Results		18/11/15	63.87KB	Share
BNO	CEO & Managing Directors AGM Presentation 2015		18/11/15	2.93MB	Share
BNO	Chairman's Address Bionomics Annual General Meeting 2015		18/11/15	125.24KB	Share
BNO	BNO and MSD Alzheimer's Disease Symposium		13/11/15	249.03KB	Share
BNO	Appendix 3B		11/11/15	118.62KB	Share
BNO	Appendix 3B		06/11/15	118.75KB	Share
BNO	Appendix 3B		05/11/15	118.61KB	Share
BNO	Appendix 3B		04/11/15	118.7KB	Share
BNO	NEW BNC105 DATA TO BE PRESENTED IN U.S.	PRICE SENSITIVE	04/11/15	68.84KB	Share
BNO	Appendix 3B		03/11/15	547.68KB	Share
BNO	Appendix 4C - quarterly	PRICE SENSITIVE	30/10/15	235.84KB	Share
BNO	Becoming a substantial holder		28/10/15	127.41KB	Share
BNO	Change of Director's Interest Notice		21/10/15	72.5KB	Share
BNO	Appendix 3B		21/10/15	118.43KB	Share
BNO	Appendix 4G / Corporate Governance Statement		16/10/15	521.81KB	Share
BNO	Bionomics Annual Report 2015		16/10/15	2.35MB	Share
BNO	Notice of Annual General Meeting/Proxy Form		16/10/15	721.91KB	Share
BNO	Cleansing Notice		12/10/15	125.41KB	Share
BNO	Appendix 3B		12/10/15	118.88KB	Share
BNO	Investor Conference Call Details		08/10/15	63.85KB	Share
BNO	Merck Investment and Pain Partnership Extended	PRICE SENSITIVE	08/10/15	68.47KB	Share
BNO	Initial Director's Interest Notice		29/09/15	65.98KB	Share
BNO	Bionomics Appoints Dr. Alan W. Dunton to Board of Directors		29/09/15	63.76KB	Share
BNO	Change of Director's Interest Notice		25/09/15	72.31KB	Share
BNO	Appendix 3B		23/09/15	118.48KB	Share
BNO	Ceasing to be a substantial holder		17/09/15	104.13KB	Share
BNO	BNO Reports Positive Data From BNC210 Clinical Trial	PRICE SENSITIVE	16/09/15	68.72KB	Share
BNO	BNC101 FDA SUBMISSION SUCCESSFUL	PRICE SENSITIVE	31/08/15	65.71KB	Share
BNO	Full Year Statutory Accounts		10/08/15	385.6KB	Share
BNO	Bionomics 2014/2015 Preliminary Final Results	PRICE SENSITIVE	10/08/15	94.23KB	Share
BNO	Bionomics Strengthens Management Team		03/08/15	61.96KB	Share
BNO	Appendix 4C - quarterly	PRICE SENSITIVE	31/07/15	131.66KB	Share
BNO	Appendix 3B		24/07/15	118.85KB	Share
BNO	Bionomics Corporate Presentation July 2015		23/07/15	2.45MB	Share
BNO	Appendix 3B		30/06/15	118.45KB	Share
BNO	Appendix 3B		18/06/15	118.72KB	Share
BNO	BNC105 Enhances Efficacy of Immuno-Oncology Therapies	PRICE SENSITIVE	15/06/15	23.09KB	Share
BNO	Bionomics NOW May 2015 Newsletter		27/05/15	553.55KB	Share
BNO	Bionomics ASX Spotlight Corporate Presentation		26/05/15	1.13MB	Share
BNO	Appendix 3B		25/05/15	119.21KB	Share
BNO	Bionomics Strengthens Leadership Team		18/05/15	28.56KB	Share
BNO	Change of Director's Interest Notice		05/05/15	72.81KB	Share
BNO	Appendix 3B		05/05/15	126.39KB	Share
BNO	Appendix 4C - quarterly	PRICE SENSITIVE	30/04/15	131.67KB	Share
BNO	Appendix 3B		27/04/15	677.36KB	Share
BNO	Bionomics Initiates Phase II BNC210 Clinical Trial	PRICE SENSITIVE	20/04/15	54.56KB	Share
BNO	Bionomics Showcases Oncology Programs at AACR Annual Meeting		17/04/15	25.01KB	Share
BNO	Change of Director's Interest Notice		15/04/15	72.72KB	Share
BNO	Appendix 3B		15/04/15	126.77KB	Share
BNO	BNC105 Biomarker Data Presented at Asian Oncology Summit		10/04/15	38.94KB	Share
BNO	Appendix 3B		30/03/15	126.48KB	Share
BNO	Appendix 3B		05/03/15	549.97KB	Share
BNO	Bionomics 2015 Corporate Presentation - February 2015		03/03/15	1.45MB	Share
BNO	Bionomics begins trading on OTCQX marketplace		02/03/15	271.13KB	Share
BNO	Bionomics to present at upcoming March US Conferences		27/02/15	102.81KB	Share
BNO	BNC105 NEW DATA	PRICE SENSITIVE	27/02/15	313.59KB	Share
BNO	Half Yearly Report and Accounts	PRICE SENSITIVE	23/02/15	837.08KB	Share
BNO	Appendix 3B		16/02/15	549.44KB	Share
BNO	Bionomics Begins Phase 1B Study With Anxiety Drug BNC210	PRICE SENSITIVE	02/02/15	43.59KB	Share
BNO	Appendix 4C - quarterly	PRICE SENSITIVE	30/01/15	98.92KB	Share
BNO	Bionomics NOW January 2015 Newsletter		12/01/15	599.27KB	Share
BNO	Bionomics CEO to Present at Biotech Showcase		12/01/15	26.63KB	Share
BNO	Bionomics CEO to Present at Biotech Showcase		12/01/15	26.61KB	Share
BNO	Change of Director's Interest Notice		04/12/14	228.29KB	Share
BNO	Appendix 3B		04/12/14	549.71KB	Share
BNO	Appendix 3B		26/11/14	126.37KB	Share
BNO	Change of Director's Interest Notice		24/11/14	72.47KB	Share
BNO	Amended Change of Director's Interest Notice		20/11/14	299.64KB	Share
BNO	BNC101 Data Presented at European Cancer Conference		20/11/14	22.34KB	Share
BNO	Change of Director's Interest Notice		18/11/14	71.35KB	Share
BNO	Appendix 3B		18/11/14	518.79KB	Share
BNO	Change of Director's Interest Notice		18/11/14	71.84KB	Share
BNO	BNC210 Data To Be Presented At US Conference		17/11/14	22.47KB	Share
BNO	Annual General Meeting 2014 Results		12/11/14	22.25KB	Share
BNO	CEO & Managing Director's AGM Presentation 2014		12/11/14	741.03KB	Share
BNO	Bionomics To Progress BNC210 In Clinical Trials	PRICE SENSITIVE	11/11/14	43.26KB	Share
BNO	Appendix 4C - quarterly	PRICE SENSITIVE	31/10/14	97.69KB	Share
BNO	Appendix 3B		16/10/14	126.76KB	Share
BNO	BNC105 Data In International Peer-Reviewed Cancer Journal	PRICE SENSITIVE	14/10/14	59.51KB	Share
BNO	Notice of Annual General Meeting/Proxy Form		10/10/14	1.66MB	Share
BNO	Bionomics Annual Report 2014		10/10/14	6.7MB	Share
BNO	Correction - BNC105 Phase II Trial Biomarker Data		29/09/14	28.97KB	Share
BNO	BNO Presents BNC105 Phase II Trial Biomarker Data	PRICE SENSITIVE	29/09/14	28.93KB	Share
BNO	Bionomics Investor Presentation		23/09/14	404.03KB	Share
BNO	Bionomics Acquires Prestwick Chemical	PRICE SENSITIVE	23/09/14	41.93KB	Share
BNO	Bionomics Receives $7.5M 2014 R&D Tax Incentive	PRICE SENSITIVE	05/09/14	37.19KB	Share
BNO	Bionomics Investor Presentation		19/08/14	500.91KB	Share
BNO	Full Year Statutory Accounts		19/08/14	1.19MB	Share
BNO	Bionomics 2013/2014 Preliminary Final Results	PRICE SENSITIVE	19/08/14	264.81KB	Share
BNO	Change of Director's Interest Notice		13/08/14	72.14KB	Share

BNO Ceasing to be a substantial holder
21/12/15		121.97KB	Share
BNO Letter to Shareholders
17/12/15		4.35MB	Share
BNO Change of Director's Interest Notice
16/12/15		72.87KB	Share
BNO Ceasing to be a substantial holder
14/12/15		88.24KB	Share
BNO Cleansing Notice
10/12/15		126.31KB	Share
BNO Appendix 3B
10/12/15		120.8KB	Share
BNO BNC210 Post Traumatic Stress Disorder Trial & Capital Raise
08/12/15	PRICE SENSITIVE	131.17KB	Share
BNO Trading Halt
04/12/15	PRICE SENSITIVE	98.28KB	Share
BNO Appendix 3B
30/11/15		119.37KB	Share
BNO Final Director's Interest Notice
19/11/15		63.84KB	Share
BNO Annual General Meeting 2015 Results
18/11/15		63.87KB	Share
BNO CEO & Managing Directors AGM Presentation 2015
18/11/15		2.93MB	Share
BNO Chairman's Address Bionomics Annual General Meeting 2015
18/11/15		125.24KB	Share
BNO BNO and MSD Alzheimer's Disease Symposium
13/11/15		249.03KB	Share
BNO Appendix 3B
11/11/15		118.62KB	Share
BNO Appendix 3B
06/11/15		118.75KB	Share
BNO Appendix 3B
05/11/15		118.61KB	Share
BNO Appendix 3B
04/11/15		118.7KB	Share
BNO NEW BNC105 DATA TO BE PRESENTED IN U.S.
04/11/15	PRICE SENSITIVE	68.84KB	Share
BNO Appendix 3B
03/11/15		547.68KB	Share
BNO Appendix 4C - quarterly
30/10/15	PRICE SENSITIVE	235.84KB	Share
BNO Becoming a substantial holder
28/10/15		127.41KB	Share
BNO Change of Director's Interest Notice
21/10/15		72.5KB	Share
BNO Appendix 3B
21/10/15		118.43KB	Share
BNO Appendix 4G / Corporate Governance Statement
16/10/15		521.81KB	Share
BNO Bionomics Annual Report 2015
16/10/15		2.35MB	Share
BNO Notice of Annual General Meeting/Proxy Form
16/10/15		721.91KB	Share
BNO Cleansing Notice
12/10/15		125.41KB	Share
BNO Appendix 3B
12/10/15		118.88KB	Share
BNO Investor Conference Call Details
08/10/15		63.85KB	Share
BNO Merck Investment and Pain Partnership Extended
08/10/15	PRICE SENSITIVE	68.47KB	Share
BNO Initial Director's Interest Notice
29/09/15		65.98KB	Share
BNO Bionomics Appoints Dr. Alan W. Dunton to Board of Directors
29/09/15		63.76KB	Share
BNO Change of Director's Interest Notice
25/09/15		72.31KB	Share
BNO Appendix 3B
23/09/15		118.48KB	Share
BNO Ceasing to be a substantial holder
17/09/15		104.13KB	Share
BNO BNO Reports Positive Data From BNC210 Clinical Trial
16/09/15	PRICE SENSITIVE	68.72KB	Share
BNO BNC101 FDA SUBMISSION SUCCESSFUL
31/08/15	PRICE SENSITIVE	65.71KB	Share
BNO Full Year Statutory Accounts
10/08/15		385.6KB	Share
BNO Bionomics 2014/2015 Preliminary Final Results
10/08/15	PRICE SENSITIVE	94.23KB	Share
BNO Bionomics Strengthens Management Team
03/08/15		61.96KB	Share
BNO Appendix 4C - quarterly
31/07/15	PRICE SENSITIVE	131.66KB	Share
BNO Appendix 3B
24/07/15		118.85KB	Share
BNO Bionomics Corporate Presentation July 2015
23/07/15		2.45MB	Share
BNO Appendix 3B
30/06/15		118.45KB	Share
BNO Appendix 3B
18/06/15		118.72KB	Share
BNO BNC105 Enhances Efficacy of Immuno-Oncology Therapies
15/06/15	PRICE SENSITIVE	23.09KB	Share
BNO Bionomics NOW May 2015 Newsletter
27/05/15		553.55KB	Share
BNO Bionomics ASX Spotlight Corporate Presentation
26/05/15		1.13MB	Share
BNO Appendix 3B
25/05/15		119.21KB	Share
BNO Bionomics Strengthens Leadership Team
18/05/15		28.56KB	Share
BNO Change of Director's Interest Notice
05/05/15		72.81KB	Share
BNO Appendix 3B
05/05/15		126.39KB	Share
BNO Appendix 4C - quarterly
30/04/15	PRICE SENSITIVE	131.67KB	Share
BNO Appendix 3B
27/04/15		677.36KB	Share
BNO Bionomics Initiates Phase II BNC210 Clinical Trial
20/04/15	PRICE SENSITIVE	54.56KB	Share
BNO Bionomics Showcases Oncology Programs at AACR Annual Meeting
17/04/15		25.01KB	Share
BNO Change of Director's Interest Notice
15/04/15		72.72KB	Share
BNO Appendix 3B
15/04/15		126.77KB	Share
BNO BNC105 Biomarker Data Presented at Asian Oncology Summit
10/04/15		38.94KB	Share
BNO Appendix 3B
30/03/15		126.48KB	Share
BNO Appendix 3B
05/03/15		549.97KB	Share
BNO Bionomics 2015 Corporate Presentation - February 2015
03/03/15		1.45MB	Share
BNO Bionomics begins trading on OTCQX marketplace
02/03/15		271.13KB	Share
BNO Bionomics to present at upcoming March US Conferences
27/02/15		102.81KB	Share
BNO BNC105 NEW DATA
27/02/15	PRICE SENSITIVE	313.59KB	Share
BNO Half Yearly Report and Accounts
23/02/15	PRICE SENSITIVE	837.08KB	Share
BNO Appendix 3B
16/02/15		549.44KB	Share
BNO Bionomics Begins Phase 1B Study With Anxiety Drug BNC210
02/02/15	PRICE SENSITIVE	43.59KB	Share
BNO Appendix 4C - quarterly
30/01/15	PRICE SENSITIVE	98.92KB	Share
BNO Bionomics NOW January 2015 Newsletter
12/01/15		599.27KB	Share
BNO Bionomics CEO to Present at Biotech Showcase
12/01/15		26.63KB	Share
BNO Bionomics CEO to Present at Biotech Showcase
12/01/15		26.61KB	Share
BNO Change of Director's Interest Notice
04/12/14		228.29KB	Share
BNO Appendix 3B
04/12/14		549.71KB	Share
BNO Appendix 3B
26/11/14		126.37KB	Share
BNO Change of Director's Interest Notice
24/11/14		72.47KB	Share
BNO Amended Change of Director's Interest Notice
20/11/14		299.64KB	Share
BNO BNC101 Data Presented at European Cancer Conference
20/11/14		22.34KB	Share
BNO Change of Director's Interest Notice
18/11/14		71.35KB	Share
BNO Appendix 3B
18/11/14		518.79KB	Share
BNO Change of Director's Interest Notice
18/11/14		71.84KB	Share
BNO BNC210 Data To Be Presented At US Conference
17/11/14		22.47KB	Share
BNO Annual General Meeting 2014 Results
12/11/14		22.25KB	Share
BNO CEO & Managing Director's AGM Presentation 2014
12/11/14		741.03KB	Share
BNO Bionomics To Progress BNC210 In Clinical Trials
11/11/14	PRICE SENSITIVE	43.26KB	Share
BNO Appendix 4C - quarterly
31/10/14	PRICE SENSITIVE	97.69KB	Share
BNO Appendix 3B
16/10/14		126.76KB	Share
BNO BNC105 Data In International Peer-Reviewed Cancer Journal
14/10/14	PRICE SENSITIVE	59.51KB	Share
BNO Notice of Annual General Meeting/Proxy Form
10/10/14		1.66MB	Share
BNO Bionomics Annual Report 2014
10/10/14		6.7MB	Share
BNO Correction - BNC105 Phase II Trial Biomarker Data
29/09/14		28.97KB	Share
BNO BNO Presents BNC105 Phase II Trial Biomarker Data
29/09/14	PRICE SENSITIVE	28.93KB	Share
BNO Bionomics Investor Presentation
23/09/14		404.03KB	Share
BNO Bionomics Acquires Prestwick Chemical
23/09/14	PRICE SENSITIVE	41.93KB	Share
BNO Bionomics Receives $7.5M 2014 R&D Tax Incentive
05/09/14	PRICE SENSITIVE	37.19KB	Share
BNO Bionomics Investor Presentation
19/08/14		500.91KB	Share
BNO Full Year Statutory Accounts
19/08/14		1.19MB	Share
BNO Bionomics 2013/2014 Preliminary Final Results
19/08/14	PRICE SENSITIVE	264.81KB	Share
BNO Change of Director's Interest Notice
13/08/14		72.14KB	Share

REFRESH

First 4 5 6 7 8

BIONOMICS LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Top Stories

Corporate Spotlight
Not Yet Available